← FDA DRUG APPROVALS

FDA ANDA · ANDA075149

TICLOPIDINE HYDROCHLORIDE

Sponsor: TEVA

APPLICATION
ANDA075149
TYPE
ANDA
ORIGINAL APPROVAL
1999-08-20
LATEST ACTION
2002-10-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TICLOPIDINE HYDROCHLORIDEDiscontinued
TICLOPIDINE HYDROCHLORIDE 250MG · TABLET · ORAL

Approval history

2002-10-16Labeling · Supplement 4AP
2002-05-28Labeling · Supplement 3AP
2001-04-20Labeling · Supplement 2AP
2001-01-29Labeling · Supplement 1AP
1999-08-20OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →